PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact


Search


PDF Archive search engine
Last database update: 06 July at 04:43 - Around 220000 files indexed.

Show results per page

Results for «metastasis»:


Total: 45 results - 0.055 seconds

Understanding Medical Terminology Associated With Cancer (5) 100%

Metastasis in the term used to describe cancer that has spread to other parts of the body.

https://www.pdf-archive.com/2012/09/18/understanding-medical-terminology-associated-with-cancer-5/

18/09/2012 www.pdf-archive.com

Spinal cord compression 95%

Compressive and non compressive disorders of spinal cord Prof.Khwaja Nazim uddin Spinal cord compression-causes •Vertebral •Meningial •Spinal cord Spinal cord compression • • More common neurological emergency Early stage of damage reversible • Severely damaged neurons donot recover • Blood supply of brain may be zeopadised by SOLs • Causes • Vertebral(80%) • Trauama • Disk prolapse • Metastatic carcinoma(breast,prostate,bronch us) • Myeloma • Tuberculosis Spinal cord compression • • More common neurological emergency Early stage of damage reversible • Severely damaged neurons donot recover • Blood supply of brain may be zeopadised by SOLs • Causes • Meninges(intradural,extramedullary )15% • Tumors(meningioma,neurofibroma,epe ndymoma,metastasis,lymphoma,leuke mias) • Spinal cord(intradural,intramedullary)5% • Glioma,ependymoma,metastasis Clinical features Usually slow(over weeks),may be acute with arterial lesion Pain and sensory symptoms occur early Weakness and sphincter dysfunction late • Symptoms of spinal cord compression •Pain :localized over the spine or in a root distribution,which may be aggravated by coughing,sneezing or straining • Sensory:paresthesia,numbness or cold sensation,specially lower limbs,which spread proximally,often to a level on the trunk • Motor:weakness,heaviness or stiffness of the limbs,most commonly the leg • Sphincter:Urgency or hesitancy of micturition,leading eventually to retention

https://www.pdf-archive.com/2017/05/20/spinal-cord-compression/

20/05/2017 www.pdf-archive.com

ayurveda and cancer ayurvedic1856 88%

The tumour is classified according to the TNM (tumour, lymph node, and metastasis) mode of classification or graded from 0 to 4, which indicate the extent and spread of the tumour and also the overall prognosis.

https://www.pdf-archive.com/2013/11/18/ayurveda-and-cancer-ayurvedic1856/

18/11/2013 www.pdf-archive.com

ayurveda and cancer ayurvedic1432 88%

The tumour is classified in line with the TNM (tumour, lymph node, and metastasis) mode of classification or graded from 0 to 4, which indicate the extent and spread from the tumour as well as the overall prognosis.

https://www.pdf-archive.com/2013/09/24/ayurveda-and-cancer-ayurvedic1432/

24/09/2013 www.pdf-archive.com

Spin Pain 87%

3.2k info@painclinicofindia.com Office ­ +91­7303142400             +91 96­99­008890 Home About Us Doctors at PCI What we Treat How we Treat Blog Fellowship Training FAQ Contact Us Welcome to the Pain Clinic of India Our clinic is one of the pioneer pain management service providers in India. Started in 2001, we are one of the most advanced clinics using latest technologies.  Our Pain Specialist Dr. Kailash Kothari is renowned globally for his contribution in India and abroad. The spine pain treatment specialists at Pain Clinic Of India are board certified and well experienced for treatment of various conditions including but not limited to, Neck and back pain Sciatica (slipped disc) Spinal Stenosis Cervical Spondylosis Failed back surgery syndrome (FBSS) Sacroiliac joint pain Pyriformis Syndrome Pain in Cancer (Head and neck, Post mastectomy lymphedema and pain, Lung, abdominal and pelvis metastasis, Spine / vertebral metastasis) Neuropathic Pain (Trigeminal, post herpetic neuralgias) Pain clinic of India Pvt. Ltd. is equipped with latest equipments and skills to provide various advanced image guided spine Pain Clinic of In… 3.2k likes pain treatments like, Trans foraminal and inter­laminar epidural steroid injections – Cervical, thoracic and lumbar Like Page Facet joint injections ­ Cervical, thoracic and lumbar Diagnostic and radiofrequency ablation of medial branches (Facet joint) ­ Cervical, thoracic and lumbar Be the first of your friends to like this Percutaneous discectomy – Nucleoplasty, Disc Fx, DeKompressor, Ozone, Nucleotome Transforaminal percutaneous endoscopic discectomy (TFED) Racz procedure (Percutaneous Neuroplasty) Spinal cord stimulation (SCS) and peripheral nerve stimulation – For FBSS, Various chronic neuralgias (Diabetic, post herpetic, and post surgical neuralgias) Intrathecal drug delivery systems (Morphine and Baclofen) – for cancer and spasticity Botox therapy Regenerative Proliferative therapies – For Knee, shoulder, tendinitis and other degenerative conditions (Dextrose Pain Clinic of India Pvt. Ltd. added 2 new photos.

https://www.pdf-archive.com/2016/12/09/spin-pain/

09/12/2016 www.pdf-archive.com

sample 81 82 83 84%

early metastasis;

https://www.pdf-archive.com/2017/12/14/sample-81-82-83/

14/12/2017 www.pdf-archive.com

Boston Biomarker Poster 03192014 81%

•They represent a heterogeneous group of cancers both in terms of tumor biology and the variety of bioactive products they synthesize and secrete, and exhibit a range of different behaviors (proliferation and/or metastasis) which reflects the diverse cells (and sites) of origin.

https://www.pdf-archive.com/2014/03/21/boston-biomarker-poster-03192014/

21/03/2014 www.pdf-archive.com

33rd Consensus Conference 80%

첫 번째 세션은 EGFR/ALK mutated lung cancer patients management 에 대한 Pros/Cons를 이야기 해보는 시간으로 마 련 하였으며, 두 번째 세션은 Brain metastasis in NSCLC patients with driver mutation management 에 대한 주제로 방사선종양학과 종양내과학 분야의 연 등록비 자를 섭외하여 각각의 관점에서 바라본 시각을 함께 듣고 토론해 보는 시간으로 구 회원 비회원 분 사전등록 현장등록 교수, 전문의, 박사급 연구원 30,000원 40,000원 전임의, 전공의, 간호사 석사급 이하 연구원 및 학생, 공보의, 군의관, 약사 20,000원 30,000원 교수, 전문의, 박사급 연구원 40,000원 50,000원 전임의, 전공의, 간호사 석사급 이하 연구원 및 학생, 공보의, 군의관, 약사 30,000원 40,000원 기타, 업체 참가 50,000원 60,000원 마련 하였습니다.

https://www.pdf-archive.com/2018/04/06/33rd-consensus-conference/

06/04/2018 www.pdf-archive.com

cv-pantel 80%

Mathematical Modeling in Hematopoiesis 1 Postgraduate career since 2016 Professor (10%) of Medicine, University of Bergen, Norway since 2015 Member of the Executive Board of the University Cancer Center Hamburg – Hubertus Wald Tumor Center since 06/2002 Director of the new Institute of Tumor Biology, Full Professor (C4) of Medicine, University Hospital Eppendorf (UKE), University of Hamburg, Germany since 2002 Coordinator of the Oncology Research Program at UKE 09/2002 – 08/2008 Deputy Director of the new Center of Experimental Medicine, UKE 01/1999 – 05/2002 Professor (C3) in Molecular Genetics, Department of Gynecology and Obstetrics, University Hospital Eppendorf, University of Hamburg, Germany Head of Molecular Oncology, Department of Gynecology and Obstetrics, University Hospital Eppendorf, University of Hamburg, Germany 07/1995 – 12/1998 Associate Professor (“Privatdozent”), Institute of Immunology, LudwigMaximilians-University, Munich, Germany 06/1989 – 12/1998 Research Scientist, Head, Micrometastasis Research Laboratory, Institute for Immunology, Ludwig-Maximilians-University, Munich, Germany Head, Project Group “Early metastasis of epithelial tumours”, Tumor Centre Munich, Germany Scientific Head of the Animal Care Unit, Institute of Immunology 05/1987 – 05/1989 Postdoctoral DFG-Fellow , Research Associate, Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, USA 06/1986 – 04/1987 Research Associate, Department of Biostatistics, Medical Institute of Environmental Hygiene, Düsseldorf, Germany Editorial and Publishing Activities Cancer Research, Clinical Cancer Research, British Journal of Cancer, Molecular Oncology, Breast Cancer Research Selected Professional Memberships:

https://www.pdf-archive.com/2018/03/19/cv-pantel/

19/03/2018 www.pdf-archive.com

27th Consensus Conference 79%

Management of brain metastasis from NSCLC 14:00 - 14:20 20min Recent controversy of whole brain radiotherapy 14:20 - 14:40 20min Defining the role of radiosurgery 14:40 - 15:00 20min Emerging role of target therapy for CNS metastasis 15:00 - 15:10 10min Q&A 15:10 - 15:20 10min Coffee break Session 3.

https://www.pdf-archive.com/2018/04/06/27th-consensus-conference/

06/04/2018 www.pdf-archive.com

CV (2) 75%

Patent Application n° 60/899,303 “Metastasis specific splice variants of Mena and uses thereof in diagnosis, prognosis and treatment of tumors”.

https://www.pdf-archive.com/2017/01/26/cv-2/

26/01/2017 www.pdf-archive.com

cvfile 0022301 (1) 75%

Preoperative prediction model of lymph node metastasis in endometrial cancer.

https://www.pdf-archive.com/2015/05/06/cvfile-0022301-1/

06/05/2015 www.pdf-archive.com

Minesh P Mehta CV 74%

2013-Present Research Mentor, Adam Reese, MD, U Maryland, Stereotactic Radiosurgery plus Lapatinib and Capecitabine in HER2-positive Breast Cancer with Brain Metastasis:

https://www.pdf-archive.com/2016/08/11/minesh-p-mehta-cv/

11/08/2016 www.pdf-archive.com

Bowel cancer 73%

T refers to the measure of tumour growth, L refers to measure of growth to lymph nodes and M or Metastasis measures if cancer is spread to other parts of the body’ Click here:

https://www.pdf-archive.com/2016/12/05/bowel-cancer/

05/12/2016 www.pdf-archive.com

cvfile 0023228 72%

Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine:

https://www.pdf-archive.com/2015/05/10/cvfile-0023228/

10/05/2015 www.pdf-archive.com

An Overview of Basal Cell Carcinoma 70%

Metastasis of BCC is exceptionally rare, occurring in no more than 0.1% of reported cases (Khan et al.

https://www.pdf-archive.com/2013/02/24/an-overview-of-basal-cell-carcinoma/

24/02/2013 www.pdf-archive.com

ER1235 68%

The issue and risk of hyper-progression Brain metastasis as a target Aurelien Marabelle, FR Questions and Answers Coffee break Session 8 Toxicity issues with Immune Check Points inhibitors John Haanen, NL 17:15-17:45 Use of checkpoint inhibitors in patients with AID and chronic viral infections Aurelien Marabelle, FR 17:45-18:00 Questions and Answers 19:00 Networking dinner 9:00-12:30 Workshop sessions Three parallel workshop sessions with 20 delegates in each group (delegates will attend all 3 sessions on a rotation basis) 15’ Introduction based on clinical cases presented by speakers 35’ Discussion 10’ Break When to stop immunotherapy or treatment beyond progression Aurelien Marabelle, FR Workshop 2 Choosing treatment based on biomarkers Solange Peters, CH David Planchard, FR Managing toxicity John Haanen, NL Feedback on the workshops from each group Synthesis and wrap-up Aurelien Marabelle, FR John Haanen, NL

https://www.pdf-archive.com/2019/06/11/er1235/

11/06/2019 www.pdf-archive.com

is your kitchen making you1013 67%

Studies hit shown that consumption spicy foods can not exclusive growth your metastasis, but also your appetency!

https://www.pdf-archive.com/2013/08/27/is-your-kitchen-making-you1013/

27/08/2013 www.pdf-archive.com

35CNSPNC Programa-разблокирован 66%

Bruno Santiago, Pedro Santos Silva 09:00 Abertura Bruno Santiago 09:05 “Current paradigm of spinal metastasis treatment” Bart Depreitere Moderador:

https://www.pdf-archive.com/2019/05/30/35cnspncprograma-/

30/05/2019 www.pdf-archive.com

CRTOG+2017邀请函和日程 66%

第二届“众筹创新”精准肿瘤学华人论坛 华人放疗协作组 2017 年会 暨放疗质控与靶区勾画学习班 邀 请 函(第二轮) 尊敬的 教授: 为促进学科发展,由世界华人肿瘤医师协会华人放疗协作组(CRTOG)和山 东省抗癌协会共同主办的第二届“众筹创新”精准肿瘤学论坛暨华人放疗协作组 2017 年会定于 7 月 7 至 9 日在山东济南召开,来自美国、欧洲、澳洲、港台和 中国大陆的华人肿瘤专家将就当前学术热点和临床工作展开讨论。 华人放疗协作组将召开全委会,开放委员/青年委员的增补申请,并筹建国 际交流和放疗质控及各常见单癌种的工作委员会,专项负责推进国际交流和放疗 质控及相应病种 MDT、临床试验和规范诊疗,诚邀相关专业的华人专家加入。其 中,国际交流工作委员会邀请外语好(≥6 级)、有国际交流工作热情的学者加 入,将在国际专家指导下开展工作,要求研究生学历、职称、年龄不限。放疗质 控委员会邀请放疗医生、物理师、技师、影像专家、设备专家等共同参与;各单 癌种工作委员会在邀请放疗专家的同时,也欢迎内、外、影像、病理等领域专家 代表加入,以方便 MDT 和临床试验的开展;要求委员具备副高以上职称,青年委 员具备中级职称或博士学位,年龄不超过 45 周岁。同时,CRTOG 将启动《肿瘤 精准诊断与治疗》丛书编写,诚邀有影响有建树的专家学者加入编委会。 请委员申请人和参会代表务必在 2017 年 6 月 30 日前发送电子回执至 office@crtog.org,CRTOG 执行委员会和各工作委员会的委员若确有事由不能出 席会议,需派代表参加并注册,授予国家级继续教育 I 类学分 10 分。 我们诚挚邀请相关领域专家学者参加本次盛会,感谢您的大力支持! 大会主席 于金明 李宝生 Co-chair 孔凤鸣 金见悦 甄维宁 岳 宁 执行主席 袁双虎 尹 勇 2017 年 6 月 21 日 第二届“众筹创新”精准肿瘤学论坛 华人放疗协作组 2017 年会暨放疗质控与靶区勾画学习班 会议日程 7月7日 09:00-13:00 报到 济南鲁能希尔顿酒店 地址:济南市市中区二环南路 2888 号 11:30-13:00 自助午餐 第一会场 精准肿瘤学论坛 地点:鲁能大宴会厅 1 厅 7 月 7 日 下午 13:00-13:30 开幕式 主持:王向东教授 袁双虎教授 CRTOG 指导主委、山东抗癌协会理事长于金明院士致欢迎辞 世界华人医师协会兼中国医师协会会长张雁灵教授致辞 世界华人肿瘤医师协会夏景林主委致辞 《肿瘤精准诊断与治疗》丛书编篡启动仪式 13:30-15:35 上半场 主持:宋启斌 尹勇 马学真 13:30-13:55 Adaptive radiation therapy for non-small cell lung cancer Feng-Ming Spring Kong 美国印第安纳大学 13:55-14:20 精准放射肿瘤学新实践 于金明 山东省肿瘤医院 14:20-14:45 惰性淋巴瘤的放疗 李晔雄 中国医学科学院肿瘤医院 14:45-15:10 小细胞肺癌的治疗进展 傅小龙 上海市胸科医院 15:10-15:35 Clinical application of molecular markers detection based on liquid biopsy in precision managment of NSCLC 王洁 中国医学科学院肿瘤医院 15:35-15:45 茶歇 15:45-18:00 下半场 主持:程玉峰 孙新臣 张述 15:45-16:10 Biophysics models and bio markers to predict patient radio sensitivity and survival Jian-Yue Jin Indian University USA 16:10-16:35 细胞周期与放疗抵抗 叶棋浓 中国军事医学科学院 16:35-17:00 抗肿瘤分子靶点鉴定与靶向治疗 贾立军 复旦大学附属肿瘤医院 17:00-17:25 胰腺癌个体化精准治疗—离我们有多远? 虞先濬 复旦大学附属肿瘤医院 17:25-17:50 乳腺癌精准靶向治疗进展 陈策实 中国科学院昆明动物研究所 18:00-20:00 晚餐 20:30-21:30 CRTOG 全委会和各工作委员会筹备会议 7 月 8 日 上午 08:00-08:30 CRTOG 各工作委员会成立仪式 08:30-10:20 上半场 主持:胡旭东 主持:王旬果 刘相燕 杨哲 08:30-08:55 肺癌放射外科和免疫治疗结合研究进展 Joe Chang 美国 MD Anderson Cancer Center 08:55-09:15 肺癌精准微创外科与快速康复 牟巨伟 中国医学科学院肿瘤医院 09:15-09:35 晚期肺癌精准医学临床转化性实践 洪专 江苏省肿瘤医院 09:35-10:00 Radiotherapy of brain metastasis for patients with lung cancer Weining Zhen Nebraska University Medical Center,USA 10:00-10:20 ALK 阳性肺癌的全程管理 方健 北京大学肿瘤医院 10:20-10:30 休息 10:30-12:00 下半场 主持:陈嘉 许孝新 孙昌进 10:30-10:55 食管癌之放疗优化 李宝生 山东省肿瘤医院 10:55-11:20 食管癌的精准外科治疗进展 刘家全 台湾和信治癌中心医院 11:20-11:40 食管癌的靶向治疗进展 袁双虎 山东省肿瘤医院 11:40-12:00 液态活检技术 ctDNA 在肿瘤治疗中的应用进展 汪笑男 世和基因公司 12:15-13:15 卫星会(午餐) 阿帕替尼在胃癌中的应用 阿帕替尼的多肿瘤应用研究进展 王潍博 山东省立医院 王启鸣 河南省肿瘤医院 7 月 8 日下午 13:30-15:30 上半场 主持:胡钦勇 陈绍水 潘绵顺 13:30-13:55 Recent progress in radiotherapy of head and neck cancers:

https://www.pdf-archive.com/2018/01/30/crtog-2017/

30/01/2018 www.pdf-archive.com

Global Radiotherapy Market.PDF 65%

The factors such as availability of alternative therapy, inability to be used for metastasis state of cancer and side effects like skin rashes are likely to hinder the global radiotherapy market.

https://www.pdf-archive.com/2017/10/12/global-radiotherapy-market/

12/10/2017 www.pdf-archive.com

MURAGIANNI2016 64%

9) Journal of Cancer Metastasis and Treatment.

https://www.pdf-archive.com/2017/04/19/muragianni2016/

19/04/2017 www.pdf-archive.com

CVE-FABBRI-CARLO-20160708174230 59%

EUS-FNA diagnosis of single pancreatic metastasis of liposarcoma.

https://www.pdf-archive.com/2018/03/30/cve-fabbri-carlo-20160708174230/

30/03/2018 www.pdf-archive.com

3147.full 59%

VEGF-C facilitates tumor metastasis via the lymphatic vessels and tumor spread can be inhibited by blocking the interaction between VEGF-C and its receptor.

https://www.pdf-archive.com/2015/07/25/3147-full/

25/07/2015 www.pdf-archive.com

ER1234 57%

T- CEL L AN D O THE R IM MU NO THERAP IES IN CAN CE R - 8.40- 9.00 HUMAN PLASMA AND SERUM EXTRACELLULAR SMALL RNA REFERENCE PROFILES AND THEIR CLINICAL UTILITY/ KLAAS MAX, (THOMAS TUSCHL LAB) ROCKEFELLER UNIVERSITY, NY, USA 9.09.20 LONG NON-CODING RNA ROLE IN BREAST CANCER IN BONE AND BRAIN METASTASIS/ SHOUYU WANG, NANJING MEDICAL UNIVERSITY, NANJING, CHINA 9.20- 9.40 CIRCULATING TUMOR CELLS AND MicroRNAS IN BREAST CANCER PATIENTS/ SOFIA AGELAKI, UNIVERSITY OF CRETE, HERAKLION, GREECE 8.15-8.45 NATURAL KILLER T CELLS IN CANCER IMMUNOTHERAPY - RECENT PROGRESS AND CHALLENGES/ MADHAV V.

https://www.pdf-archive.com/2019/06/11/er1234/

11/06/2019 www.pdf-archive.com